Cancer Markers
Cancer Markers contains revenue assessment, analysis, and competitive review for tests for oncology using biomarkers. Multiple firms manufacture a range of technologies – histology/cytology, immunohistochemistry, in situ hybridization, immunoassays - tumor markers, flow cytometry, rapid tests, and molecular marker-based technologies – to determine risk for cancer, screen for cancer, test for cancer, and help in prognosis and personalization of therapy.
Cancer Markers provides the following information: global cancer biomarkers diagnostic revenues, 2015 and 2020 (IHC, ISH, immunoassays, flow, rapid, molecular); global cancer biomarkers diagnostic market percentage (IHC, ISH, flow cytometry, molecular-based assays, NMP22, FOB, PSA, CEA, CA125, AFP, other tumor markers); selected extensively used tumor markers; selected biomarkers and biomarker panels to determine risk of cancer, and manufacturers developing/marketing these biomarkers; selected biomarkers and biomarker panels for cancer screening, and manufacturers developing/marketing these biomarkers; selected biomarkers and biomarker panels for diagnosis and/or monitoring of cancer, and manufacturers developing/marketing these biomarkers; selected biomarkers and biomarker panels to predict prognosis of cancer, and manufacturers developing/marketing these biomarkers; selected biomarkers and biomarker panels to predict response to therapy, and manufacturers developing/marketing these biomarkers; selected FDA-cleared/approved companion diagnostic tests, and manufacturers developing/marketing these biomarkers; selected manufacturers developing/marketing cancer tests; common next generation molecular test traits; selected sample preparation reagents; and selected cancer test innovations, 2015. Abbott Laboratories, Alere Inc., bioMérieux SA, Hologic, Inc., Illumina, Inc., QIAGEN N.V., Roche, and Thermo Fisher Scientific, Inc. are among the manufacturers discussed in the competitive analysis.
- Executive Summary
- MARKET
- SCOPE AND METHODOLOGY
- Introduction
- Table Estimated Global Incidence and Mortality due to Cancer, 2012 – By Regions of the World
- Table Selected Widely Used Tumor Markers
- CANCER RISK ASSESSMENT
- Table Selected Biomarkers and Biomarker Panels to Assess Risk of Cancer, and Companies Developing/Marketing These Biomarkers
- CANCER SCREENING
- Table Selected Biomarkers and Biomarker Panels for Cancer Screening, and Companies Developing/Marketing These Biomarkers
- CANCER MONITORING
- Table Selected Biomarkers and Biomarker Panels for Diagnosis and/or Monitoring of Cancer, and Companies Developing/Marketing These Biomarkers
- CANCER PROGNOSIS ASSESSMENT
- Table Selected Biomarkers and Biomarker Panels to Predict Prognosis of Cancer, and Companies Developing/Marketing These Biomarkers
- PERSONALIZED MEDICINE/PRECISION TESTING
- Table Selected Biomarkers and Biomarker Panels to Predict Response to Therapy, and Companies Developing/Marketing These Biomarkers
- Table Selected FDA Cleared/Approved Companion Diagnostic Tests, and Companies Developing/Marketing These Biomarkers
- COMPETITION IN CANCER BIOMARKERS
- Table Selected Companies Developing/Marketing Cancer Tests
- MOLECULAR MARKERS
- Table Common Next Generation Molecular Test Traits
- PRECISION MEDICINE
- Table Selected Sample Preparation Reagents
- Table Selected Cancer Test Innovations, 2015
- Cancer Markers Market Analysis
- Table Worldwide Cancer Biomarkers Diagnostic Market – 2015 and 2020 (IHC, ISH, Immunoassays, Flow, Rapid, Molecular) $ millions
- Table Selected International Agreements
- Company Profiles
- 20/20 GENESYSTEMS, INC.
- ABBOTT LABORATORIES
- Recent Revenue History
- Agreements
- ABCODIA LTD.
- Financings
- ALERE INC. (ABBOTT)
- AMBRY GENETICS CORP.
- ASURAGEN, INC.
- Diagnostic Products
- Translational/Companion Diagnostics
- Agreements
- ATHENA DIAGNOSTICS, INC. (AQUEST DIAGNOSTICS BUSINESS)
- BIOMÉRIEUX SA
- Recent Revenue History
- Company Overview
- Immunodiagnostics for Lab Professionals (Clinical Laboratories)
- Molecular Diagnostics
- BIOTHERANOSTICS, INC. (A BIOMÉRIEUX COMPANY)
- CANCER GENETICS, INC.
- Recent Revenue History
- Company Overview
- Agreements
- GENOMIC HEALTH, INC.
- Recent Revenue History
- GENOPTIX (A NOVARTIS COMPANY)
- HOLOGIC, INC.
- Recent Revenue History
- Company Overview
- ILLUMINA, INC.
- Recent Revenue History
- Company Overview
- MYRIAD GENETICS, INC.
- Recent Revenue History
- Company Overview
- QIAGEN N.V.
- Recent Revenue History
- ROCHE
- Recent Revenue History
- Company Overview
- Roche Professional Diagnostics
- Molecular Diagnostics
- Tissue Diagnostics
- THERMO FISHER SCIENTIFIC, INC.
- Recent Revenue History
- Company Overview
- WAKO PURE CHEMICAL INDUSTRIES, LTD.,
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook